Capabilities
Strategic Advisory
Restructuring & Recapitalization
Independent Board Advice
Capital Advisory
Transactions
Our Team
Careers
Community
Contact Us
Shareholder Activism
Skip Navigation Links
strategic advisory
restructuring & recapitalization
independent board advice
special committee
shareholder activism
capital advisory
Recent Transactions
EsoBiotec
Announced: Q1 2025
Value: Up to $1.0 billion
Status: Pending
Exclusive financial advisor to EsoBiotec on its acquisition by AstraZeneca
View All
Career Opportunities
At Centerview Partners, our success depends on our people, and we are always looking for talented individuals. Please
let us know
if you would like to learn more about a career at Centerview.
Our Team
Our Partners have worked on many of the largest and most complex transactions and corporate situations around the globe over the course of their careers.
Learn more
about who we are.